Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Osteoporosis and Sarcopenia
>
2021
>
7
>
3
Volume:
7
Issue:
3
1. Intervention thresholds to identify postmenopausal women with high fracture risk: A single center study based on the Philippines FRAX model
Page:98—102
2. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture
Page:115—120
3. Prevalence of osteoporosis in elderly women in Hong Kong
Page:92—97
4. Romosozumab and cardiovascular safety in Japan
Page:89—91
5. Osteoporosis treatment rates after hip fracture 2011e2019 in Hawaii:Undertreatment of men after hip fractures
Page:103—109
6. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study
Page:110—114
7. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture
Page:115—120
8. Intervention thresholds to identify postmenopausal women with high fracture risk: A single center study based on the Philippines FRAX model
Page:98—102
9. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture
Page:115—120
10. Prevalence of osteoporosis in elderly women in Hong Kong
Page:92—97
11. Romosozumab and cardiovascular safety in Japan
Page:89—91
12. Osteoporosis treatment rates after hip fracture 2011e2019 in Hawaii:Undertreatment of men after hip fractures
Page:103—109
13. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study
Page:110—114
14. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture
Page:115—120